LncRNA | MiRNA | Gene | Gene name | Pathway Name | Description | Title | Disease/Tissue | Journal | PubMed ID |
LINC00052 | miR-193a-3p | AKT | AKT2;:HIHGHH;PKBB;PKBBETA;PRKBB;RAC-BETA | details
Cholinergic synapse;HIF-1 signaling pathway;Chemokine signaling pathway;MAPK signaling pathway;Small cell lung cancer;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;T cell receptor signaling pathway;ErbB signaling pathway;Carbohydrate digestion and absorption;Chagas disease (American trypanosomiasis);mTOR signaling pathway;PI3K-Akt signaling pathway;Hepatitis B;HTLV-I infection;Pathways in cancer;Toxoplasmosis;Colorectal cancer;Endometrial cancer;Jak-STAT signaling pathway;Neurotrophin signaling pathway;Influenza A;Proteoglycans in cancer; Measles;Dopaminergic synapse;Tuberculosis;Prostate cancer;Non-small cell lung cancer;Apoptosis;Progesterone-mediated oocyte maturation;Melanoma;Chronic myeloid leukemia; B cell receptor signaling pathway; Insulin signaling pathway;Renal cell carcinoma;Estrogen signaling pathway;VEGF signaling pathway;Osteoclast differentiation;Glioma;Epstein-Barr virus infection; Focal adhesion;Tight junction;Hepatitis C;Fc gamma R-mediated phagocytosis;Pancreatic cancer;Acute myeloid leukemia;Adipocytokine signaling pathway
|
details
Collectively, our findings established Linc00152 as a candidate prognostic indicator of outcome and drug responsiveness in colon cancer patients, and the involvement of competing endogenous RNAs mechanism in Linc00152/miR-193a-3p/ERBB4/AKT signaling axis may provide a novel choice in the investigation of drug resistance.
|
details
Linc00153 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer
|
Colon Cancer | Mol Ther | 27633443 |
LINC00052 | miR-193a-3p | ERBB4 | ERBB4;ALS19;HER4;p180erbB4 | details
ErbB signaling pathway;Calcium signaling pathway;Endocytosis;Proteoglycans in cancer
|
details
Collectively, our findings established Linc00152 as a candidate prognostic indicator of outcome and drug responsiveness in colon cancer patients, and the involvement of competing endogenous RNAs mechanism in Linc00152/miR-193a-3p/ERBB4/AKT signaling axis may provide a novel choice in the investigation of drug resistance.
|
details
Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer
|
Colon Cancer | Mol Ther | 27633443 |
LINC00052 | miR-128 | NTRK3 | NTRK3GP145-TrkC;TRKC;gp145(trkC) | details
Neurotrophin signaling pathway
|
details
Meanwhile, we discovered that LINC00052 could regulate NTRK3 expression by forming complementary base pairing with miR-128 and miR-485-3p to reduce the luciferase activity of NTRK3 3'UTR.
|
details
LINC00052 regulates the expression of NTRK3 by miR-128 and miR-485-3p to strengthen HCC cells invasion and migration
|
Hepatocarcinoma | Oncotarget | 27351280 |
LINC00052 | miR-485-3p | NTRK3 | NTRK3GP145-TrkC;TRKC;gp145(trkC) | details
Neurotrophin signaling pathway
|
details
Meanwhile, we discovered that LINC00052 could regulate NTRK3 expression by forming complementary base pairing with miR-128 and miR-485-3p to reduce the luciferase activity of NTRK3 3'UTR.
|
details
LINC00052 regulates the expression of NTRK3 by miR-128 and miR-485-3p to strengthen HCC cells invasion and migration
|
Hepatocarcinoma | Oncotarget | 27351280 |